ERCROS, S.A. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.54 EUR | +0.28% |
|
-0.42% | +34.09% |
| Apr. 10 | Ercros Hires Advisers for Bondalti Ibérica’s EUR329 Million Takeover Bid | MT |
| Mar. 05 | Bondalti Ibérica launched a public takeover offer to acquire Ercros, S.A. for ?330 million . | CI |
| Sales 2024 * | 772M 824M | Sales 2025 * | 825M 881M | Capitalization | 324M 346M |
|---|---|---|---|---|---|
| Net income 2024 * | 23M 24.56M | Net income 2025 * | 35M 37.37M | EV / Sales 2024 * | 0.55 x |
| Net Debt 2024 * | 101M 108M | Net Debt 2025 * | 89.5M 95.56M | EV / Sales 2025 * | 0.5 x |
| P/E ratio 2024 * |
13.6
x | P/E ratio 2025 * |
9.08
x | Employees | - |
| Yield 2024 * |
1.84% | Yield 2025 * |
2.54% | Free-Float | 84.17% |
More Fundamentals
* Assessed data
More news
More press releases
More news
| 1 day | +0.28% | ||
| 1 week | -0.42% | ||
| Current month | +0.85% | ||
| 1 month | +2.91% | ||
| 3 months | +43.32% | ||
| 6 months | +23.99% | ||
| Current year | +34.09% |
1 week
3.53
3.58
1 month
3.433.60
Current year
2.263.60
1 year
2.264.80
3 years
2.264.81
5 years
1.414.81
10 years
0.385.57
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 78 | 96-06-13 | |
| Director of Finance/CFO | 59 | 05-12-31 | |
Sebastián Sosa
CTO | Chief Tech/Sci/R&D Officer | 65 | 83-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 62 | 96-07-28 | |
| Director/Board Member | 71 | 04-06-17 | |
| Chief Executive Officer | 78 | 96-06-13 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-17 | 3.54 | +0.28% | 50,424 |
| 24-04-16 | 3.53 | -0.28% | 49,545 |
| 24-04-15 | 3.54 | -0.42% | 66,869 |
| 24-04-12 | 3.555 | 0.00% | 54,830 |
| 24-04-11 | 3.555 | 0.00% | 56,735 |
Delayed Quote BME, April 17, 2024 at 11:35 am EDT
More quotes
Ercros SA is a Spain-based company engaged, together with its subsidiaries, in the chemical industry. The Companyâs products are structured into three business lines: Businesses Associated to Chlorine, which comprises the production of chlorine, ethyl acetate, caustic soda, sodium hypochlorite, dichloroethane, chloromethane, sodium chlorate and caustic potash, polyvinyl chloride (PCV), as well as water disinfectants; Intermediate Chemicals, which produces formaldehyde, glues and resins for the fiberboard and plywood industries, and Pharmaceuticals, which comprises raw material and intermediate products used in the pharmaceutical industry. The Company owns such subsidiaries as Marcoating SLU, Gades Ltd and Ercekol AIE, among others. In April 2014, it sold Fosfatos de Cartagena SLU to Timab Iberica.
Sector
Commodity Chemicals
Calendar
2024-05-14
- Q1 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
3.54
EUR
Average target price
4.4
EUR
Spread / Average Target
+24.29%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +34.09% | 343M | |
| +5.89% | 103B | |
| -1.92% | 65.66B | |
| +30.48% | 38.6B | |
| +13.36% | 37.74B | |
| +4.86% | 32.27B | |
| +6.17% | 19.3B | |
| +14.62% | 17.07B | |
| +19.29% | 14.86B | |
| +7.05% | 14.76B |
- Stock Market
- Equities
- ECR Stock
